Related Experiment Video
Updated: Sep 23, 2025

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
Published on: August 17, 2022
COVID-19 Vaccine Challenges in Developing and Developed Countries
Harshani Yarlagadda1, Meet A Patel2, Vasu Gupta3
1Internal Medicine, Avalon University School of Medicine, Willemstad, CUW.
Insights
The COVID-19 pandemic caused distress, leading to vaccine development. Challenges remain in vaccine accessibility, affordability, and acceptance globally, differing between developed and developing nations.
Area of Science:
- Public Health
- Epidemiology
- Vaccinology
Background:
- The COVID-19 pandemic resulted in widespread psychological and economic hardship.
- Rapid development of COVID-19 vaccines occurred within a year of the pandemic declaration.
Purpose of the Study:
- To examine the multifaceted challenges in achieving global herd immunity against COVID-19.
- To identify disparities in vaccine-related challenges between developed and developing countries.
Main Methods:
- Review of pandemic response strategies.
- Analysis of global vaccine distribution and uptake data.
- Comparative assessment of vaccine challenges across different economic contexts.
Main Results:
- Key challenges include vaccine development, affordability, accessibility, and individual/country-level acceptance.
- Developed nations primarily face vaccine acceptance issues.
- Developing nations grapple with vaccine affordability and accessibility.
Conclusions:
- Global herd immunity for COVID-19 is hindered by distinct challenges in different countries.
- Addressing vaccine acceptance in developed nations and affordability/accessibility in developing nations is crucial for pandemic control.
Abstract:
The coronavirus disease 2019 (COVID-19) pandemic has led to significant psychological and economical distress. Within a year after COVID-19 was declared a pandemic, several vaccines against COVID-19 were approved for emergency use. The journey from vaccine discovery to global herd immunity against COVID-19 continues to present significant challenges revolving around its development, affordability, accessibility, and acceptability at both a country level and an individual level. The main challenge faced by developed countries is the acceptability of the COVID-19 vaccine and the main challenge faced by developing countries is the affordability and accessibility of the COVID-19 vaccine.
Related Concept Videos
Vaccinations
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Microorganisms in Medicine and Therapeutics
Immunodeficiency Diseases
There are three main causes of immunodeficiency...

